Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03267069 · ClinicalTrials.gov registry record
Evaluating Alcohol Use in Alcoholic Liver Disease
A clinical trial of Alcoholic Liver Disease, sponsored by Nicole T Shen.
- Recruiting
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT03267069 is a study of Alcoholic Liver Disease that is actively recruiting participants, run by Nicole T Shen. The registered enrollment target is 160 participants, above the 45-participant average among 5 other Alcoholic Liver Disease trials with a reported enrollment target (256% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03267069, a study of Alcoholic Liver Disease, is actively recruiting participants, sponsored by Nicole T Shen.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
Conditions Studied
Interventions
- OTHER survey
Study Locations (1)
New York
- New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-11-27 |
| Est. Completion | 2027-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03267069
The ClinicalTrials.gov registry entry for NCT03267069 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 5 other Alcoholic Liver Disease trials with a reported enrollment target (256% higher). The listed sponsor is Nicole T Shen, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcoholic Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which survey is the first listed.
NCT03267069 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03267069 about?
NCT03267069 is a clinical study titled "Evaluating Alcohol Use in Alcoholic Liver Disease". This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
What is the current status of trial NCT03267069?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2016-11-27. Estimated completion is 2027-11-01.
What conditions does trial NCT03267069 study?
This clinical trial studies the following conditions: Alcoholic Liver Disease.
What interventions are being tested in trial NCT03267069?
The interventions under investigation include: survey (OTHER).
Who is sponsoring clinical trial NCT03267069?
This trial is sponsored by Nicole T Shen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03267069 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholic Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
RECRUITING · NA
-
Ethanol Induces Skeletal Muscle Autophagy
RECRUITING
-
Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)
ACTIVE NOT RECRUITING
-
Alcoholic Liver Disease and the Gut Microbiome
ACTIVE NOT RECRUITING · NA
-
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.